Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.78 USD | +6.27% | -9.44% | -39.93% |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- The group shows a rather high level of debt in proportion to its EBITDA.
- The company is not the most generous with respect to shareholders' compensation.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-39.93% | 1.91B | B- | ||
-2.31% | 185B | C+ | ||
-3.20% | 105B | C | ||
-5.04% | 66.59B | A | ||
+0.20% | 54.66B | B- | ||
+17.29% | 47.78B | B- | ||
+4.06% | 41.26B | B+ | ||
+2.36% | 26.95B | A- | ||
+2.07% | 26.37B | B | ||
+12.96% | 24.8B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CNMD Stock
- Ratings CONMED Corporation